|
2020-07-29 |
2020-07-28 |
B
Purchase
|
LA JOLLA PHARMACEUTICAL CO
Large shareholder
|
3,737,360
+344.5%
2.00
USD 7,474,720
|
3,737,360
+344.5%
|
2.00
|
USD 7,474,720
|
|
|
2020-06-22 |
2020-06-19 |
B
Purchase
|
LA JOLLA PHARMACEUTICAL CO
Large shareholder
|
234,698
+27.6%
2.62
USD 613,993
|
234,698
+27.6%
|
2.62
|
USD 613,993
|
|
|
2019-12-12 |
2019-12-10 |
S
Sale
|
Freund John Gordon
Non-Executive Director
|
524
-100.0%
2.19
USD 1,148
|
524
-100.0%
|
2.19
|
USD 1,148
|
|
|
2019-12-12 |
2019-12-10 |
S
Sale
|
Freund John Gordon
Non-Executive Director
|
14,507
-100.0%
2.19
USD 31,770
|
14,507
-100.0%
|
2.19
|
USD 31,770
|
|
|
2019-12-09 |
2019-12-06 |
S
Sale
|
Macdonald Guy
Non-Executive Director
|
5,735
-95.8%
2.25
USD 12,903
|
5,735
-95.8%
|
2.25
|
USD 12,903
|
|
|
2019-12-09 |
2019-12-05 |
S
Sale
|
Macdonald Guy
Non-Executive Director
|
1,870
-23.8%
2.34
USD 4,377
|
1,870
-23.8%
|
2.34
|
USD 4,377
|
|
|
2019-01-10 |
2019-01-08 |
PS
Planned sale
|
Dumas Jacques
Chief ScientificOfficer
Officer
|
7,497
-100.0%
1.60
USD 11,995
|
7,497
-100.0%
|
1.60
|
USD 11,995
|
|
|
2018-01-31 |
2018-01-30 |
PS
Planned sale
|
Dumas Jacques
Chief ScientificOfficer
Officer
|
8,750
-100.0%
6.22
USD 54,425
|
8,750
-100.0%
|
6.22
|
USD 54,425
|
|
|
2018-01-11 |
2018-01-09 |
PS
Planned sale
|
Dumas Jacques
Chief ScientificOfficer
Officer
|
7,167
-100.0%
6.21
USD 44,507
|
7,167
-100.0%
|
6.21
|
USD 44,507
|
|
|
2017-12-04 |
2017-11-29 |
B
Purchase
|
GAGE L PATRICK
|
3,880
+11.1%
6.45
USD 25,026
|
3,880
+11.1%
|
6.45
|
USD 25,026
|
|
|
2017-11-02 |
2017-10-31 |
PS
Planned sale
|
Dumas Jacques
Chief ScientificOfficer
|
8,750
-100.0%
6.03
USD 52,763
|
8,750
-100.0%
|
6.03
|
USD 52,763
|
|
|
2017-08-24 |
2017-08-22 |
PS
Planned sale
|
Dumas Jacques
Chief ScientificOfficer
|
17,500
-100.0%
6.00
USD 105,000
|
17,500
-100.0%
|
6.00
|
USD 105,000
|
|
|
2017-08-21 |
2017-08-17 |
PS
Planned sale
|
Dumas Jacques
Chief ScientificOfficer
|
7,155
-100.0%
5.86
USD 41,928
|
7,155
-100.0%
|
5.86
|
USD 41,928
|
|
|
2017-03-16 |
2017-03-15 |
B
Purchase
|
GAGE L PATRICK
Non-Executive Director
|
1,000
+35.4%
7.47
USD 7,470
|
1,000
+35.4%
|
7.47
|
USD 7,470
|
|
|
2017-03-16 |
2017-03-15 |
B
Purchase
|
GAGE L PATRICK
Non-Executive Director
|
10,000
+40.0%
7.49
USD 74,900
|
10,000
+40.0%
|
7.49
|
USD 74,900
|
|
|
2015-09-10 |
2015-09-08 |
PS
Planned sale
|
THOMPSON JOHN CRAIG
Chief Operating Officer
Officer
|
10,000
-96.7%
44.08
USD 440,800
|
10,000
-96.7%
|
44.08
|
USD 440,800
|
|
|
2015-09-03 |
2015-09-01 |
PS
Planned sale
|
Macdonald Guy
President and Chief Executive
Executive Director
|
10,000
-16.1%
41.57
USD 415,700
|
10,000
-16.1%
|
41.57
|
USD 415,700
|
|
|
2015-08-17 |
2015-08-14 |
PS
Planned sale
|
Lubner David Charles
SVP and CFO
Officer
|
9,500
-12.1%
42.92
USD 407,740
|
9,500
-12.1%
|
42.92
|
USD 407,740
|
|
|
2015-08-17 |
2015-08-13 |
PS
Planned sale
|
Horn Patrick Taylor
Chief Medical Officer
Officer
|
10,000
-100.0%
44.69
USD 446,900
|
10,000
-100.0%
|
44.69
|
USD 446,900
|
|
|
2015-08-14 |
2015-08-12 |
S
Sale
|
GAGE L PATRICK
Non-Executive Director
|
15,000
-75.0%
45.00
USD 675,000
|
15,000
-75.0%
|
45.00
|
USD 675,000
|
|
